Results 51 to 60 of about 1,279 (113)

[Nicolau syndrome due to self-injectable drugs in multiple sclerosis]. [PDF]

Rev Neurol, 2023
Neri MJ, Mulero P, Téllez N.
europepmc   +1 more source

Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria. [PDF]

Rev Neurol, 2023
Milanov I, Ivanova S, Tournev I, Chamova T, Kaprelyan A, Slavov G, Chervenkov V, Kipriyanovska K.   +7 more
europepmc   +1 more source

Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE

Journal of Immunology Research, 2014
Background and Objectives. Resistant and susceptible mouse strains to experimental autoimmune encephalomyelitis (EAE), an inducible demyelinating experimental disease serving as animal model for multiple sclerosis, have been described.
Nieves Marín, Miriam Mecha, Carmen Espejo, Leyre Mestre, Herena Eixarch, Xavier Montalban, José C. Álvarez-Cermeño, Carmen Guaza, Luisa M. Villar   +8 more
doaj   +1 more source

ePoster

European Journal of Neurology, Volume 32, Issue S1, June 2025.
wiley   +1 more source

Cultural adaptation and validation of a peninsular Spanish version of the MSTCQ© (Multiple Sclerosis Treatment Concerns Questionnaire)

Neurología (English Edition), 2017
Introduction: Although subcutaneous treatments for multiple sclerosis (MS) have been shown to be effective, adverse reactions and pain may adversely affect treatment satisfaction and adherence. This study presents an adapted and validated Spanish version
E. Muntéis Olivas, G. Navarro Mascarell, J. Meca Lallana, A. Maestre Martínez, Á. Pérez Sempere, J. Gracia Gil, A. Pato Pato   +6 more
doaj   +1 more source

Adaptación cultural y validación al español de España del MSTCQ© (Multiple Sclerosis Treatment Concerns Questionnaire)

Neurología, 2017
Resumen: Introducción: A pesar de la efectividad de los tratamientos inyectables para la esclerosis múltiple (EM), las reacciones adversas y el dolor pueden implicar problemas de satisfacción y adherencia.
E. Muntéis Olivas, G. Navarro Mascarell, J. Meca Lallana, A. Maestre Martínez, Á. Pérez Sempere, J. Gracia Gil, A. Pato Pato   +6 more
doaj   +1 more source

[Esclerosis multiple. Lactancia. Lactante. Planificacion familiar. Posparto. Tratamiento modificador de la enfermedad.] [PDF]

Rev Neurol, 2023
Sánchez-Velasco S, Midaglia L, Vidal-Jordana A, Castillo F, Horno R, Carreras E, Serrano B, Bosch M, Agustí A, Montalban X, Tintoré M.   +10 more
europepmc   +1 more source

[Actual adherence to dimethyl fumarate in patients with relapsing-remitting multiple sclerosis]. [PDF]

Rev Neurol, 2023
de Sá J, Ferreira J, Macedo AM.
europepmc   +1 more source

COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis

Frontiers in Immunology
ObjectiveTo evaluate the safety of COVID-19 vaccines in patients with multiple sclerosis (MS) by assessing their impact on serum neurofilament light chain (sNfL) levels as a marker of neuroaxonal damage.MethodsSingle-center observational longitudinal ...
Susana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Raquel Sainz-Amo, Raquel Sainz-Amo, Lucienne Costa-Frossard, Jaime Masjuan, Luisa María Villar   +11 more
doaj   +1 more source

[Family planning in men and women with multiple sclerosis. Analysis of the Andalusian Registry (2018-2022)]. [PDF]

Rev Neurol, 2023
Vidal-de Francisco D, Rosa-Garrido C, Ruiz-de Arcos M, Romero-Villarrubia A, Romero-Tellado M, Alonso-Torres AM, Delgado-Gil V, Agüera-Morales E, Díaz-Sánchez M, Piñar-Morales R, Muñoz-Fernández C, Pacheco-Cortegana EM, Durán-Ferreras E, Arnal-García MC, Mendibe-Bilbao MM, Rodríguez-Antigüedad A.   +15 more
europepmc   +1 more source